MRNA stock · NG stock

MRNA vs NG · rev $145.0M vs $1.96B cap

Moderna Inc (MRNA) versus NovaGold Resources Inc (NG) — a side-by-side from cached financials, not a winner call.

Moderna Inc (MRNA) is a biotechnology company listed on NASDAQ. It is led by Stephane Bancel.

NovaGold Resources Inc (NG) is a gold company listed on US.

Latest reported MRNA revenue for 2026-06-30 was $145.0M. Net income was -$782.0M. Revenue was down 62.7% from 2026-03-31 to 2026-06-30. MRNA currently screens at market cap $24.52B.

Latest reported NG revenue for 2026-05-31 was $0. Net income was -$40.9M. NG currently screens at market cap $1.96B.

MRNA currently screens at market cap $24.52B. NG currently screens at market cap $1.96B.

Not investment advice. Open the MRNA and NG stock pages for the full models.

Not investment advice.

Popular Stock Comparisons